Burning Rock Biotech Limited (BNR)

Burning Rock Biotech Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	452.72	519.85	615.1	905.45	1,431	1,895
Short-Term Investments	-	6.14	13.41	2.09	65.63	367.39
Cash & Short-Term Investments	452.72	525.99	628.5	907.55	1,497	2,263
Cash Growth	-14.99%	-16.31%	-30.75%	-39.37%	-33.84%	450.69%
Accounts Receivable	204.72	165.87	149.61	151.71	134.59	110.75
Other Receivables	-	0.18	1.18	0.1	0.11	2.23
Receivables	204.72	166.05	150.79	151.81	138.2	112.98
Inventory	57.81	62.63	69.02	130.32	123.21	68.02
Restricted Cash	2.3	2.31	0.12	19.82	7.8	29.9
Other Current Assets	23.25	19.65	35.67	49.27	54.79	50.06
Total Current Assets	740.81	776.62	884.1	1,259	1,821	2,524
Property, Plant & Equipment	77.14	100.34	144.2	300.03	406.45	111.48
Long-Term Investments	-	-	0.34	0.69	0.91	1.42
Other Intangible Assets	0.35	0.42	0.96	1.99	5.15	3.46
Other Long-Term Assets	6.63	7.93	5.09	20.89	45.14	23.02
Total Assets	824.93	885.31	1,040	1,587	2,279	2,663
Accounts Payable	32.16	33.75	18.06	50.95	63.08	35.48
Accrued Expenses	75.12	56.94	65.37	104.23	107.03	71.89
Short-Term Debt	-	-	-	-	2.37	7.37
Current Portion of Long-Term Debt	0.2	-	-	-	-	34.7
Current Portion of Leases	19.26	24.57	8.63	37.24	35	4.82
Current Income Taxes Payable	-	14.46	20.62	11.03	7.69	6.99
Current Unearned Revenue	102.8	117.9	130.54	147.63	142.87	74.4
Other Current Liabilities	0.59	18.69	20.14	60.38	14.14	5.89
Total Current Liabilities	230.13	266.3	263.36	411.45	372.18	241.53
Long-Term Debt	1.8	-	-	-	-	-
Long-Term Leases	17.87	27.75	3.69	13.55	49.32	-
Long-Term Unearned Revenue	-	-	-	-	-	0.26
Other Long-Term Liabilities	10.89	10.43	4.54	4.12	11.78	0.23
Total Liabilities	260.7	304.48	271.59	429.13	433.28	242.02
Common Stock	0.15	0.15	0.14	0.14	0.14	0.14
Additional Paid-In Capital	5,007	5,002	4,849	4,583	4,281	4,007
Retained Earnings	-4,223	-4,200	-3,854	-3,200	-2,229	-1,418
Treasury Stock	-60.92	-63.26	-65.9	-58.92	-	-
Comprehensive Income & Other	-158.36	-158.05	-161.53	-165.72	-207.07	-167.59
Total Common Equity	564.24	580.83	768.41	1,158	1,845	2,421
Shareholders' Equity	564.24	580.83	768.41	1,158	1,845	2,421
Total Liabilities & Equity	824.93	885.31	1,040	1,587	2,279	2,663
Total Debt	39.13	52.32	12.32	50.79	86.69	46.88
Net Cash (Debt)	413.6	473.66	616.18	856.76	1,410	2,216
Net Cash Growth	-2.60%	-23.13%	-28.08%	-39.25%	-36.35%	545.24%
Net Cash Per Share	39.21	46.02	60.18	82.45	135.33	322.84
Filing Date Shares Outstanding	10.77	10.77	10.26	10.27	10.52	10.45
Total Common Shares Outstanding	10.77	10.76	10.24	10.26	10.51	10.48
Working Capital	510.68	510.32	620.73	847.31	1,449	2,282
Book Value Per Share	52.40	53.97	75.01	112.85	175.56	231.05
Tangible Book Value	563.88	580.41	767.45	1,156	1,840	2,418
Tangible Book Value Per Share	52.37	53.93	74.92	112.66	175.07	230.72
Machinery	-	307.49	348.07	339.09	297.89	180.54
Construction In Progress	-	0.63	0.55	2.66	27.56	1.09
Leasehold Improvements	-	187.23	187.39	187.38	161.04	30.67

Updated Sep 8, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q